{"title":"某专科医院294例新冠肺炎患者ABO-Rh血型与预后的关系","authors":"Perveen RA, Nasir M, Pervin S, Zahan T, Farha N","doi":"10.47648/jmsr.2022.v3201.01","DOIUrl":null,"url":null,"abstract":"Aim: The rapid global spread of the novel corona virus SARS-CoV-2 has strained healthcare and testing resources, making the identification and prioritization of individuals most at-risk became a critical challenge. Recent evidence suggests blood type may affect the risk of severe COVID-19.Method: In this cross-sectional observational study, among 1348 admitted patients in Holy Family Red Crescent Medical College who tested positive for RT-PCR, 294 patients were included with known blood type to assess the association between ABO and Rh blood types and demographic profile, co-morbidities, clinical outcomes, and changes in the biomarkers. Result: among 294 patients admitted to the hospital with COVID-19, the mean age was 48 to 49 years. Out of all patients, 211 were male, and 83 were female, with a ratio of 1: 2.54. The highest numbers of patients were between 50-59 years. The highest percentage of diabetic patients were present in the AB blood group (54%), and hypertensive patients in the O and Rh-negative blood group (40.29%, 60%) which were statistically not significant. Other than that, COPD, IHD, and CKD were observed. Symptoms of patients were categorized as inflammatory and neurological. Shortness of breath (52.41%), fever (38.43%), and cough (28.23%) were observed among inflammatory symptoms, which were statistically significant and lethargy (16.25%) was only remarkable neurological involvement. Among all ABO blood groups, 'A' blood group of patients, present with a higher percentage of both inflammatory and neurological symptoms. Among the Rh blood group, Rh-negative patients did not present with diarrhea, sore throat, lethargy, anosmia, and loss of taste. Changes in biomarkers levels were also observed in all blood groups. Conclusion: COVID-19 patients with blood group A or B are at increased risk of disease severity with the highest number of co morbidities and symptoms compared with patients with blood group O or AB.","PeriodicalId":315974,"journal":{"name":"Journal of Medical Science & Research","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association and Outcome of ABO-Rh Blood Group among 294 COVID-19 Patients admitted in A Dedicated Hospital\",\"authors\":\"Perveen RA, Nasir M, Pervin S, Zahan T, Farha N\",\"doi\":\"10.47648/jmsr.2022.v3201.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The rapid global spread of the novel corona virus SARS-CoV-2 has strained healthcare and testing resources, making the identification and prioritization of individuals most at-risk became a critical challenge. Recent evidence suggests blood type may affect the risk of severe COVID-19.Method: In this cross-sectional observational study, among 1348 admitted patients in Holy Family Red Crescent Medical College who tested positive for RT-PCR, 294 patients were included with known blood type to assess the association between ABO and Rh blood types and demographic profile, co-morbidities, clinical outcomes, and changes in the biomarkers. Result: among 294 patients admitted to the hospital with COVID-19, the mean age was 48 to 49 years. Out of all patients, 211 were male, and 83 were female, with a ratio of 1: 2.54. The highest numbers of patients were between 50-59 years. The highest percentage of diabetic patients were present in the AB blood group (54%), and hypertensive patients in the O and Rh-negative blood group (40.29%, 60%) which were statistically not significant. Other than that, COPD, IHD, and CKD were observed. Symptoms of patients were categorized as inflammatory and neurological. Shortness of breath (52.41%), fever (38.43%), and cough (28.23%) were observed among inflammatory symptoms, which were statistically significant and lethargy (16.25%) was only remarkable neurological involvement. Among all ABO blood groups, 'A' blood group of patients, present with a higher percentage of both inflammatory and neurological symptoms. Among the Rh blood group, Rh-negative patients did not present with diarrhea, sore throat, lethargy, anosmia, and loss of taste. Changes in biomarkers levels were also observed in all blood groups. Conclusion: COVID-19 patients with blood group A or B are at increased risk of disease severity with the highest number of co morbidities and symptoms compared with patients with blood group O or AB.\",\"PeriodicalId\":315974,\"journal\":{\"name\":\"Journal of Medical Science & Research\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Science & Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47648/jmsr.2022.v3201.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Science & Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47648/jmsr.2022.v3201.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Association and Outcome of ABO-Rh Blood Group among 294 COVID-19 Patients admitted in A Dedicated Hospital
Aim: The rapid global spread of the novel corona virus SARS-CoV-2 has strained healthcare and testing resources, making the identification and prioritization of individuals most at-risk became a critical challenge. Recent evidence suggests blood type may affect the risk of severe COVID-19.Method: In this cross-sectional observational study, among 1348 admitted patients in Holy Family Red Crescent Medical College who tested positive for RT-PCR, 294 patients were included with known blood type to assess the association between ABO and Rh blood types and demographic profile, co-morbidities, clinical outcomes, and changes in the biomarkers. Result: among 294 patients admitted to the hospital with COVID-19, the mean age was 48 to 49 years. Out of all patients, 211 were male, and 83 were female, with a ratio of 1: 2.54. The highest numbers of patients were between 50-59 years. The highest percentage of diabetic patients were present in the AB blood group (54%), and hypertensive patients in the O and Rh-negative blood group (40.29%, 60%) which were statistically not significant. Other than that, COPD, IHD, and CKD were observed. Symptoms of patients were categorized as inflammatory and neurological. Shortness of breath (52.41%), fever (38.43%), and cough (28.23%) were observed among inflammatory symptoms, which were statistically significant and lethargy (16.25%) was only remarkable neurological involvement. Among all ABO blood groups, 'A' blood group of patients, present with a higher percentage of both inflammatory and neurological symptoms. Among the Rh blood group, Rh-negative patients did not present with diarrhea, sore throat, lethargy, anosmia, and loss of taste. Changes in biomarkers levels were also observed in all blood groups. Conclusion: COVID-19 patients with blood group A or B are at increased risk of disease severity with the highest number of co morbidities and symptoms compared with patients with blood group O or AB.